Discovery of novel natural products as rhodesain inhibitors for human African trypanosomiasis using in silico techniques

References

• Alsford, S., Currier, R. B., Guerra-Assunção, J. A., Clark, T. G., & Horn, D. (2014). Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei. PLoS Pathogens, 10(5), e1004130. https://doi.org/10.1371/journal.ppat.1004130
   PubMed Web of Science ®Google Scholar
• Alzain, A. A., & Elbadwi, F. A. (2021). Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies. Informatics in Medicine Unlocked, 26, 100758. https://doi.org/10.1016/j.imu.2021.100758
   PubMedGoogle Scholar
• Amnerkar, N. D., & Bhusari, K. P. (2010). Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. European Journal of Medicinal Chemistry, 45(1), 149–159. https://doi.org/10.1016/j.ejmech.2009.09.037
   PubMed Web of Science ®Google Scholar
• Baker, C. H., & Welburn, S. C. (2018). The long wait for a new drug for human African Trypanosomiasis. Trends in Parasitology, 34(10), 818–827. https://doi.org/10.1016/j.pt.2018.08.006
   PubMed Web of Science ®Google Scholar
• Banerjee, H., & Rachubinski, R. A. (2017). Involvement of SNARE protein Ykt6 in glycosome biogenesis in Trypanosoma brucei. Molecular and Biochemical Parasitology, 218, 28–37. https://doi.org/10.1016/j.molbiopara.2017.10.003
   PubMed Web of Science ®Google Scholar
• Banik, A., Ghosh, K., Patil, U. K., & Gayen, S. (2021). Identification of molecular fingerprints of natural products for the inhibition of breast cancer resistance protein (BCRP). Phytomedicine: international Journal of Phytotherapy and Phytopharmacology, 85, 153523. https://doi.org/10.1016/j.phymed.2021.153523
   PubMed Web of Science ®Google Scholar
• Beteck, R. M., Legoabe, L. J., Isaacs, M., Khanye, S. D., Laming, D., & Hoppe, H. C. (2019). Anti-trypanosomal and antimalarial properties of tetralone derivatives and structurally related benzocycloalkanones. Med, 55(5), 206–211. https://doi.org/10.3390/medicina55050206
   Google Scholar
• Bhadoriya, K. S., Kumawat, N. K., Bhavthankar, S. V., Avchar, M. H., Dhumal, D. M., Patil, S. D., & Jain, S. V. (2016). Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential melastatin 8 (TRPM8) antagonists using MLR and kNN-MFA methodology. J. Saudi Chem. Soc, 20, S256–S270. https://doi.org/10.1016/j.jscs.2012.11.001
   Web of Science ®Google Scholar
• Bhadoriya, K. S., Sharma, M. C., Sharma, S., Jain, S. V., & Avchar, M. H. (2014). An approach to design potent anti-Alzheimer’s agents by 3D-QSAR studies on fused 5,6-bicyclic heterocycles as γ-secretase modulators using kNN-MFA methodology. Arab. J. Chem, 7(6), 924–935. https://doi.org/10.1016/j.arabjc.2013.02.002
   Web of Science ®Google Scholar
• Bindseil, K. U., Jakupovic, J., Wolf, D., Lavayre, J., Leboul, J., & Van Der Pyl, D. (2001). Pure compound libraries; a new perspective for natural product based drug discovery. Drug Discovery Today, 6(16), 840–847. https://doi.org/10.1016/S1359-6446(01)01856-6
   PubMed Web of Science ®Google Scholar
• Blum, A., Mudji, J., Grize, L., Burri, C., Zellweger, M. J., & Blum, J. (2020). Sleeping hearts: 12 years after a follow up study on cardiac findings due to sleeping sickness. One Health (Amsterdam, Netherlands), 11, 100182. https://doi.org/10.1016/j.onehlt.2020.100182
   PubMed Web of Science ®Google Scholar
• Brun, R., Blum, J., Chappuis, F., & Burri, C. (2010). Human African trypanosomiasis. Lancet (London, England), 375(9709), 148–159. https://doi.org/10.1016/S0140-6736(09)60829-1
   PubMed Web of Science ®Google Scholar
• Büscher, P., Cecchi, G., Jamonneau, V., & Priotto, G. (2017). Human African trypanosomiasis. Lancet (London, England), 390(10110), 2397–2409. https://doi.org/10.1016/S0140-6736(17)31510-6
   PubMed Web of Science ®Google Scholar
• Chtita, S., Ghamali, M., Ousaa, A., Aouidate, A., Belhassan, A., Taourati, A. I., Masand, V. H., Bouachrine, M., & Lakhlifi, T. (2019). QSAR study of anti-Human African Trypanosomiasis activity for 2-phenylimidazopyridines derivatives using DFT and Lipinski’s descriptors. Heliyon, 5(3), e01304. https://doi.org/10.1016/j.heliyon.2019.e01304
   PubMed Web of Science ®Google Scholar
• Correia, M. M. G., Barboza, J. V. M., & Espíndola, A. L. (2021). Sleeping sickness: An agent-based model approach. Physica A: Statistical Mechanics and its Applications, 582, 126282. https://doi.org/10.1016/j.physa.2021.126282
   Web of Science ®Google Scholar
• Elbadwi, F. A., Khairy, E. A., Alsamani, F. O., Mahadi, M. A., Abdalrahman, S. E., Ahmed, Z. A. M., Elsayed, I., Ibraheem, W., & Alzain, A. A. (2021). Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Informatics in Medicine Unlocked, 26, 100725. https://doi.org/10.1016/j.imu.2021.100725
   PubMedGoogle Scholar
• Enanga, B., Burchmore, R. J. S., Stewart, M. L., & Barrett, M. P. (2002). Sleeping sickness and the brain. Cellular and Molecular Life Sciences: CMLS, 59(5), 845–858. https://doi.org/10.1007/s00018-002-8472-0
   PubMed Web of Science ®Google Scholar
• Franco, J., Scarone, L., & Comini, M. A. (2020). Novel distamycin analogues that block the cell cycle of African trypanosomes with high selectivity and potency. Eur. J. Med. Chem, 189, 112043. https://doi.org/10.1016/j.ejmech.2020.112043
   PubMed Web of Science ®Google Scholar
• Frier, B. M. (2014). Hypoglycaemia in diabetes mellitus: Epidemiology and clinical implications. Nature Reviews. Endocrinology, 10(12), 711–722. https://doi.org/10.1038/nrendo.2014.170
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Galiano, V., Garcia-Valtanen, P., Micol, V., & Encinar, J. A. (2016). Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach. Drug Design, Development and Therapy, ume 10, 3163–3181. https://doi.org/10.2147/DDDT.S117369
   Web of Science ®Google Scholar
• Gao, J. M., Qian, Z. Y., Hide, G., Lai, D. H., Lun, Z. R., & Wu, Z. D. (2020). Human African trypanosomiasis: The current situation in endemic regions and the risks for non-endemic regions from imported cases. Parasitology, 147(9), 922–931. https://doi.org/10.1017/S0031182020000645
   PubMed Web of Science ®Google Scholar
• Giroud, M., Dietzel, U., Anselm, L., Banner, D., Kuglstatter, A., Benz, J., Blanc, J., Gaufreteau, D., Liu, H., Lin, X., Stich, A., Kuhn, B., Schuler, F., Kaiser, M., Brun, R., Schirmeister, T., & Kisker, C. (2018). Repurposing a library of human Cathepsin L Ligands: Identification of macrocyclic lactams as potent rhodesain and trypanosoma brucei inhibitors, https://doi.org/10.1021/acs.jmedchem.7b01869
   Google Scholar
• Greenwood, J. R., Calkins, D., Sullivan, A. P., & Shelley, J. C. (2010). Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. Journal of Computer-Aided Molecular Design, 24(6-7), 591–604. https://doi.org/10.1007/s10822-010-9349-1
   PubMed Web of Science ®Google Scholar
• Hassan, M. D., Castanha, R. C. G., & Wolfram, D. (2020). Scientometric analysis of global trypanosomiasis research: 1988–2017. Journal of Infection and Public Health, 13(4), 514–520. https://doi.org/10.1016/j.jiph.2019.10.006
   PubMed Web of Science ®Google Scholar
• Helikumi, M., Lolika, P. O., & Mushayabasa, S. (2021). Implications of seasonal variations, host and vector migration on spatial spread of sleeping sickness: Insights from a mathematical model. Informatics Med. Unlocked, 24, 100570. https://doi.org/10.1016/j.imu.2021.100570
   Google Scholar
• Jacobson, M. P., Friesner, R. A., Xiang, Z., & Honig, B. (2002). On the role of the crystal environment in determining protein side-chain conformations. Journal of Molecular Biology, 320(3), 597–608. https://doi.org/10.1016/S0022-2836(02)00470-9
   PubMed Web of Science ®Google Scholar
• Janežič, M., Valjavec, K., Loboda, K. B., Herlah, B., Ogris, I., Kozorog, M., Podobnik, M., Grdadolnik, S. G., Wolber, G., & Perdih, A. (2021). Dynophore-based approach in virtual screening: A case of human DNA topoisomerase IIα. International Journal of Molecular Sciences, 22(24), 13474. https://doi.org/10.3390/ijms222413474
   PubMed Web of Science ®Google Scholar
• Johé, P., Jaenicke, E., Neuweiler, H., Schirmeister, T., Kersten, C., & Hellmich, U. A. (2021). Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes. The Journal of Biological Chemistry, 296, 100565. https://doi.org/10.1016/j.jbc.2021.100565
   PubMed Web of Science ®Google Scholar
• Kato, C. D., Nanteza, A., Mugasa, C., Edyelu, A., Matovu, E., & Alibu, V. P. (2015). Clinical profiles, disease outcome and co- Morbidities among T.b. rhodesiense sleeping sickness patients in uganda. PLoS One, 10(2), e0118370–13. https://doi.org/10.1371/journal.pone.0118370
   PubMed Web of Science ®Google Scholar
• KB, S., Kumari, A., Shetty, D., Fernandes, E., DV, C., Jays, J., & Murahari, M. (2020). Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis. Journal of Molecular Graphics & Modelling, 101, 107718. https://doi.org/10.1016/j.jmgm.2020.107718
   PubMed Web of Science ®Google Scholar
• Kennedy, P. G. E. (2008). The continuing problem of human African trypanosomiasis (sleeping sickness). Annals of Neurology, 64(2), 116–126. https://doi.org/10.1002/ana.21429
   PubMed Web of Science ®Google Scholar
• Kennedy, P. G. E. (2013). Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). The Lancet. Neurology, 12(2), 186–194. https://doi.org/10.1016/S1474-4422(12)70296-X
   PubMed Web of Science ®Google Scholar
• Kennedy, P. G. E., & Rodgers, J. (2019). Clinical and neuropathogenetic aspects of human African trypanosomiasis. Frontiers in Immunology, 10, 39–11. https://doi.org/10.3389/fimmu.2019.00039
   PubMed Web of Science ®Google Scholar
• Kerr, I. D., Lee, J. H., Farady, C. J., Marion, R., Rickert, M., Sajid, M., Pandey, K. C., Caffrey, C. R., Legac, J., Hansell, E., Mckerrow, J. H., Craik, C. S., Rosenthal, P. J., & Brinen, L. S. (2009). Vinyl sulfones as antiparasitic agents and a structural basis for drug design. The Journal of Biological Chemistry, 284(38), 25697–25703. https://doi.org/10.1074/jbc.M109.014340
   PubMed Web of Science ®Google Scholar
• Kerr, I. D., Wu, P., Marion-tsukamaki, R., Mackey, Z. B., & Brinen, L. S. (2010). Crystal Structures of TbCatB and Rhodesain. Potential Chemotherapeutic Targets and Major Cysteine Proteases of Trypanosoma brucei, 4, 1–10. https://doi.org/10.1371/journal.pntd.0000701
   Google Scholar
• Lascano, S., Lopez, M., & Arimondo, P. B. (2018). Natural products and chemical biology tools: Alternatives to target epigenetic mechanisms in cancers. Chemical Record (New York, N.Y.), 18(12), 1854–1876. https://doi.org/10.1002/tcr.201800133
   PubMed Web of Science ®Google Scholar
• MacroModel. (2020). Schrödinger, LLC.
   Google Scholar
• Matetovici, I., De Vooght, L., & Van Den Abbeele, J. (2019). Innate immunity in the tsetse fly (Glossina), vector of African trypanosomes. Developmental and Comparative Immunology, 98, 181–188. https://doi.org/10.1016/j.dci.2019.05.003
   PubMed Web of Science ®Google Scholar
• Meisner, J., Barnabas, R. V., & Rabinowitz, P. M. (2019). A mathematical model for evaluating the role of trypanocide treatment of cattle in the epidemiology and control of Trypanosoma brucei rhodesiense and T. b. gambiense sleeping sickness in Uganda, Parasite Epidemiol. Parasite Epidemiology and Control, 5, e00106. https://doi.org/10.1016/j.parepi.2019.e00106
   PubMedGoogle Scholar
• Mesu, V., Kalonji, W. M., Bardonneau, C., Mordt, O. V., Blesson, S., Simon, F., Delhomme, S., Bernhard, S., Kuziena, W., Lubaki, J. P. F., Vuvu, S. L., Ngima, P. N., Mbembo, H. M., Ilunga, M., Bonama, A. K., Heradi, J. A., Solomo, J. L. L., Mandula, G., Badibabi, L. K., … Tarral, A. (2018). Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: A pivotal multicentre, randomised, non-inferiority trial. Lancet (London, England), 391(10116), 144–154. https://doi.org/10.1016/S0140-6736(17)32758-7
   PubMed Web of Science ®Google Scholar
• Nasution, M. A. F., Toepak, E. P., Alkaff, A. H., & Tambunan, U. S. F. (2018). Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): A computational approach to discover new drug for combating Ebola. BMC Bioinformatics, 19(S14) . https://doi.org/10.1186/s12859-018-2387-8
   Google Scholar
• Obi, C. F., Nzeakor, T. A., Okpala, M. I., Ezeh, I. O., Nwobi, L. G., Omeje, M. O., & Ezeokonkwo, R. C. (2019). Evaluation of antitrypanosomal activity of Pterocarpus santalinoides L’H’erit ex DC hydroethanol leaf extract in rats experimentally infected with Trypanosoma brucei. J. Ethnopharmacol, 243, 112085. https://doi.org/10.1016/j.jep.2019.112085
   PubMed Web of Science ®Google Scholar
• Palmer, J. T., Rasnick, D., Klaus, J. L., & Brömme, D. (1995). Vinyl Sulfones as Mechanism-Based Cysteine Protease Inhibitors. Journal of Medicinal Chemistry, 38(17), 3193–3196. https://doi.org/10.1021/jm00017a002
   PubMed Web of Science ®Google Scholar
• Pamer, E. G., Davis, C. E., & So, M. (1991). Expression and deletion analysis of the Trypanosoma brucei rhodesiense cysteine protease in Escherichia coli. Infection and Immunity, 59(3), 1074–1078. https://doi.org/10.1128/iai.59.3.1074-1078.1991
   PubMed Web of Science ®Google Scholar
• Pays, E., & Nolan, D. P. (2021). Genetic and immunological basis of human African trypanosomiasis. Current Opinion in Immunology, 72, 13–20. https://doi.org/10.1016/j.coi.2021.02.007
   PubMed Web of Science ®Google Scholar
• Perdih, A., Hrast, M., Pureber, K., Barreteau, H., Grdadolnik, S. G., Kocjan, D., Gobec, S., Solmajer, T., & Wolber, G. (2015). Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): Experimental and computational characterization. Journal of Computer-Aided Molecular Design, 29(6), 541–560. https://doi.org/10.1007/s10822-015-9843-6
   PubMed Web of Science ®Google Scholar
• Pereira, G. A. N., da Silva, E. B., Braga, S. F. P., Leite, P. G., Martins, L. C., Vieira, R. P., Soh, W. T., Villela, F. S., Costa, F. M. R., Ray, D., de Andrade, S. F., Brandstetter, H., Oliveira, R. B., Caffrey, C. R., Machado, F. S., & Ferreira, R. S. (2019). Discovery and characterization of trypanocidal cysteine protease inhibitors from the ‘malaria box. European Journal of Medicinal Chemistry, 179, 765–778. https://doi.org/10.1016/j.ejmech.2019.06.062
   PubMed Web of Science ®Google Scholar
• Pogorelčnik, B., Brvar, M., Žegura, B., Filipič, M., Solmajer, T., & Perdih, A. (2015). Discovery of mono- and disubstituted 1H-pyrazolo[3,4]pyrimidines and 9H-purines as catalytic inhibitors of human DNA topoisomerase IIα. ChemMedChem, 10(2), 345–359. https://doi.org/10.1002/cmdc.201402459
   PubMed Web of Science ®Google Scholar
• QikProp. (2020). Schrödinger, LLC.
   Google Scholar
• Ramachandran, R., & Piramanyagam, S. (2017). Pharmacophore modeling, atom based 3D-QSAR and molecular docking approaches to screen C-X-C chemokine receptor type 4 antagonists as microbicides for human immunodeficiency virus-1. VirusDisease, 28(3), 272–280. https://doi.org/10.1007/s13337-017-0397-1
   PubMedGoogle Scholar
• Riyaphan, J., Jhong, C. H., Lin, S. R., Chang, C. H., Tsai, M. J., Lee, D. N., Sung, P. J., Leong, M. K., & Weng, C. F. (2018). Hypoglycemic efficacy of docking selected natural compounds against α-glucosidase and α-amylase. Molecules, 23(9), 2260. https://doi.org/10.3390/molecules23092260
   PubMed Web of Science ®Google Scholar
• Rodgers, J., Steiner, I., & Kennedy, P. G. E. (2019). Generation of neuroinflammation in human African trypanosomiasis. Neurol. Neuroimmunol. Neuroinflammation, 6 https://doi.org/10.1212/NXI.0000000000000610.
   Google Scholar
• Ruiz-Torres, V., Losada-Echeberría, M., Herranz-López, M., Barrajón-Catalán, E., Galiano, V., Micol, V., & Encinar, J. A. (2018). New mammalian target of rapamycin (mTOR) modulators derived from natural product databases and marine extracts by using molecular docking techniques. Mar. Drugs, 16(10), 385–324. https://doi.org/10.3390/md16100385
   PubMed Web of Science ®Google Scholar
• Salam, N. K., Nuti, R., & Sherman, W. (2009). Novel method for generating structure-based pharmacophores using energetic analysis. Journal of Chemical Information and Modeling, 49(10), 2356–2368. https://doi.org/10.1021/ci900212v
   PubMed Web of Science ®Google Scholar
• Schirmeister, T., Kesselring, J., Jung, S., Schneider, T. H., Weickert, A., Becker, J., Lee, W., Bamberger, D., Wich, P. R., Distler, U., Tenzer, S., Johé, P., Hellmich, U. A., & Engels, B. (2016). Quantum chemical-based protocol for the rational design of covalent inhibitors. Journal of the American Chemical Society, 138(27), 8332–8335. https://doi.org/10.1021/jacs.6b03052
   PubMed Web of Science ®Google Scholar
• Schirmeister, T., Schmitz, J., Jung, S., Schmenger, T., Krauth-Siegel, R. L., & Gütschow, M. (2017). Evaluation of dipeptide nitriles as inhibitors of rhodesain, a major cysteine protease of Trypanosoma brucei. Bioorganic & Medicinal Chemistry Letters, 27(1), 45–50. https://doi.org/10.1016/j.bmcl.2016.11.036
   PubMed Web of Science ®Google Scholar
• Scotti, L., Bezerra Mendonca, F. J., Ribeiro, F. F., Tavares, J. F., da Silva, M. S., Barbosa Filho, J. M., & Scotti, M. T. (2017). Natural product inhibitors of topoisomerases: Review and docking study, curr. Current Protein & Peptide Science, 19, 275–291. https://doi.org/10.2174/1389203718666170111114442
   Web of Science ®Google Scholar
• Seidel, T., Ibis, G., Bendix, F., & Wolber, G. (2010). Strategies for 3D pharmacophore-based virtual screening. Drug Discovery Today: Technologies, 7. https://doi.org/10.1016/j.ddtec.2010.11.004.
   Google Scholar
• Simarro, P. P., Cecchi, G., Franco, J. R., Paone, M., Diarra, A., Ruiz-Postigo, J. A., Fèvre, E. M., Mattioli, R. C., & Jannin, J. G. (2012). Estimating and Mapping the Population at Risk of Sleeping Sickness. PLoS Negl. Trop. Dis, 6. https://doi.org/10.1371/journal.pntd.0001859.
   Google Scholar
• Singh, J., Meshram, V., & Gupta, M. (2020). Bioactive natural products in drug discovery, Bioact. Nat. Prod. Drug Discov, 1–733. https://doi.org/10.1007/978-981-15-1394-7
   Google Scholar
• Subramaniyan, V., Mathiyalagan, S., Praveenkumar, A., Srinivasan, P., Palani, M., Ravichandran, V., & Nallasamy, P. (2018). Molecular docking and ADME properties of bioactive molecules against human acid-beta-glucosidase enzyme, cause of Gaucher’s disease. In Silico Pharmacology, 6(1), 3–11. https://doi.org/10.1007/s40203-018-0039-3.
   PubMedGoogle Scholar
• TA, H. (2009). Identifying and characterizing binding sites and assessing druggability. J. Chem. Inf. Model, 49, 377–389.
   PubMed Web of Science ®Google Scholar
• Thompson, A. M., Marshall, A. J., Maes, L., Yarlett, N., Bacchi, C. J., Gaukel, E., Wring, S. A., Launay, D., Braillard, S., Chatelain, E., Mowbray, C. E., & Denny, W. A. (2018). Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo. Bioorganic & Medicinal Chemistry Letters, 28(2), 207–213. https://doi.org/10.1016/j.bmcl.2017.10.067
   PubMed Web of Science ®Google Scholar
• Wall, R. J., Rico, E., Lukac, I., Zuccotto, F., Elg, S., Gilbert, I. H., Freund, Y., & Alley, M. R. K. (2018). Clinical and Veterinary Trypanocidal Benzoxaboroles Target CPSF3. https://doi.org/10.1073/pnas.1807915115
   Google Scholar
• Xu, Y., Wang, F., Guo, H., Wang, S., Ni, S., Zhou, Y., Wang, Z., Bao, H., & Wang, Y. (2019). Antitussive and anti-inflammatory dual-active agents developed from natural product lead compound 1-methylhydantoin. Molecules, 24(13), 2355–2312. https://doi.org/10.3390/molecules24132355
   PubMed Web of Science ®Google Scholar